A Phase 4, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Chronic Migraine and Medication Overuse Headache

Grants and Contracts Details

StatusFinished
Effective start/end date9/18/194/27/22

Funding

  • AMGen: $9,931.00